Zevin Asset Management LLC boosted its position in HCP, Inc. (NYSE:HCP) by 37.3% in the fourth quarter, HoldingsChannel reports. The firm owned 127,396 shares of the real estate investment trust’s stock after buying an additional 34,597 shares during the quarter. HCP comprises approximately 1.3% of Zevin Asset Management LLC’s investment portfolio, making the stock its 28th largest position. Zevin Asset Management LLC’s holdings in HCP were worth $3,558,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently bought and sold shares of HCP. Private Ocean LLC raised its holdings in HCP by 251.7% in the fourth quarter. Private Ocean LLC now owns 1,674 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 1,198 shares in the last quarter. Nvwm LLC bought a new position in HCP in the fourth quarter worth $48,000. Capital Investment Advisory Services LLC bought a new position in HCP in the fourth quarter worth $102,000. CWM LLC raised its holdings in HCP by 9.2% in the fourth quarter. CWM LLC now owns 4,064 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 341 shares in the last quarter. Finally, Private Capital Group LLC raised its holdings in HCP by 71.4% in the fourth quarter. Private Capital Group LLC now owns 4,286 shares of the real estate investment trust’s stock worth $120,000 after purchasing an additional 1,786 shares in the last quarter. Institutional investors and hedge funds own 88.78% of the company’s stock.
A number of research firms have issued reports on HCP. BMO Capital Markets upgraded HCP from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $30.00 to $33.00 in a report on Wednesday, January 9th. Robert W. Baird raised HCP from a “neutral” rating to an “outperform” rating in a research note on Monday, January 7th. Scotiabank started coverage on HCP in a research note on Monday, December 10th. They issued an “outperform” rating and a $32.00 target price on the stock. Zacks Investment Research reissued a “sell” rating on shares of HCP in a research note on Tuesday, November 13th. Finally, ValuEngine raised HCP from a “hold” rating to a “buy” rating in a research note on Monday, November 12th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $27.39.
Shares of NYSE HCP traded down $0.01 during trading on Monday, reaching $31.24. The company had a trading volume of 34,949 shares, compared to its average volume of 2,699,802. HCP, Inc. has a 12-month low of $21.48 and a 12-month high of $31.65. The stock has a market cap of $14.85 billion, a P/E ratio of 16.02, a P/E/G ratio of 13.87 and a beta of 0.46. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 1.21.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 28th. Investors of record on Tuesday, February 19th will be given a dividend of $0.37 per share. The ex-dividend date of this dividend is Friday, February 15th. This represents a $1.48 annualized dividend and a dividend yield of 4.74%. HCP’s dividend payout ratio (DPR) is presently 75.90%.
In related news, COO Thomas Klaritch sold 82,532 shares of the stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the sale, the chief operating officer now directly owns 256,280 shares of the company’s stock, valued at $7,562,822.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.14% of the company’s stock.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More: What is a Market Correction?
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.